Yu, Kenneth Ho-ming

Publications

Sort by

Co-Author Network

selected publications

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 138
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. Cancer medicine. 2019 Academic Article GET IT
Times cited: 67
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science (New York, N.Y.). 2019 Academic Article GET IT
Times cited: 176
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 46
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 25
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms. Journal of the National Cancer Institute. 2018 Academic Article GET IT
Times cited: 180
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2018 Academic Article GET IT
Times cited: 14
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience. BMC cancer. 2018 Academic Article GET IT
Times cited: 72
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. Cancers. 2018 Academic Article GET IT
Times cited: 19
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. Investigational new drugs. 2018 Academic Article GET IT
Times cited: 81
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?. Clinical colorectal cancer. 2018 Academic Article GET IT
Times cited: 13
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma. Clinical colorectal cancer. 2018 Academic Article GET IT
Times cited: 16
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 274
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma. Cancer. 2018 Academic Article GET IT
Times cited: 94
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. European journal of cancer. 2017 Academic Article GET IT
Times cited: 125
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. The oncologist. 2017 Academic Article GET IT
Times cited: 34
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. JAMA. 2017 Academic Article GET IT
Times cited: 362
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma. Cancer. 2017 Academic Article GET IT
Times cited: 33
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 80
Current management and future directions in metastatic pancreatic adenocarcinoma. Cancer. 2016 Review GET IT
Times cited: 21
Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. Clinical colorectal cancer. 2016 Academic Article GET IT
Times cited: 37
Identification of germline genetic mutations in patients with pancreatic cancer. Cancer. 2015 Academic Article GET IT
Times cited: 169
Mouse Models of Pancreatic Ductal Adenocarcinoma. Hematology/oncology clinics of North America. 2015 Information Resource GET IT
Times cited: 8
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma. Clinical colorectal cancer. 2015 Academic Article GET IT
Times cited: 20
Pharmacogenomic modeling in pancreatic cancer—response. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Article GET IT
Organoid models of human and mouse ductal pancreatic cancer. Cell. 2014 Academic Article GET IT
Times cited: 1523
Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 51
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2014 Academic Article GET IT
Times cited: 18
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. British journal of cancer. 2013 Academic Article GET IT
Times cited: 107
A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients. Journal of palliative medicine. 2013 Academic Article GET IT
Times cited: 75
Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas. The American journal of surgical pathology. 2013 Academic Article GET IT
Times cited: 36
Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. The oncologist. 2011 Academic Article GET IT
Times cited: 112
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. The oncologist. 2011 Academic Article GET IT
Times cited: 220
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011 Academic Article GET IT
Times cited: 1804
Analysis of the human pancreatic stellate cell secreted proteome. Pancreas. 2011 Academic Article GET IT
Times cited: 79
Health information exchange, biosurveillance efforts, and emergency department crowding during the spring 2009 H1N1 outbreak in New York City. Annals of emergency medicine. 2010 Academic Article GET IT
Times cited: 24
Critical aspects of emergency department documentation and communication. Emergency medicine clinics of North America. 2009 Information Resource GET IT
Times cited: 20
Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer. Journal of proteome research. 2009 Academic Article GET IT
Times cited: 46
Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry. Journal of proteome research. 2009 Academic Article GET IT
Times cited: 64
Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. Journal of proteome research. 2009 Academic Article GET IT
Times cited: 82
Treatment update for metastatic pancreatic cancer. Community Oncology. 2006 Article
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. Journal of proteome research. 2005 Academic Article GET IT
Times cited: 133
Effect of immunoaffinity depletion of human serum during proteomic investigations. Journal of proteome research. 2005 Academic Article GET IT
Times cited: 104
Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid. Leukemia. 1999 Academic Article GET IT
Times cited: 38
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis. Leukemia. 1999 Academic Article GET IT
Times cited: 72

more ...

less ...

Background

education and training

M.Sc., University of Pennsylvania 2009
M.D., The Johns Hopkins University School of Medicine 1999
B.A., Harvard University 1995

Contact

full name

Kenneth Ho-ming Yu

VIVO Weill Cornell Medical College

Kenneth Ho-ming Yu Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name